Will cabozantinib enter medical insurance in 2024?

Cabozantinib is an oral targeted therapy drug that is widely used to treat some malignant tumors, especially thyroid cancer and renal cell carcinoma. It belongs to a class of drugs called multitarget tyrosine kinase inhibitors that block key signaling pathways for tumor growth and metastasis.

Since cabozantinib is not currently available in China, patients cannot purchase it directly domestically and must obtain it through overseas channels. In overseas markets, cabozantinib exists in two types: original drugs and generic drugs. The price of original drugs is relatively high. For example, the price of original drugs in Japan and Europe is about 30,000 to 40,000 yuan. The price of generic drugs is relatively affordable. For example, the price of generic versions of drugs in Laos, India and Bangladesh fluctuates between a few hundred to several thousand yuan. It is worth noting that the ingredients of these original drugs and generic drugs are basically the same.

The main mechanism of action of cabozantinib includes inhibiting tumor angiogenesis, reducing tumor cells' demand for nutrients, and inhibiting tumor cell proliferation and survival. This makes it an effective treatment option, especially for patients who are insensitive or resistant to other treatments.

In the treatment of thyroid cancer, cabozantinib is often used in patients with advanced or metastatic thyroid cancer, especially in patients whose disease has progressed despite having received other treatments. For renal cell carcinoma, it is also used in first-line treatment and post-progression treatment.

Although cabozantinib is an effective treatment, it may also cause some side effects, including high blood pressure, hand-foot syndrome, proteinuria, and dry mouth. Therefore, when using this drug, doctors usually evaluate the patient's specific situation and regularly monitor their reactions and side effects to ensure the effectiveness and safety of the treatment.

Overall, cabozantinib is a drug that has shown good efficacy in the treatment of certain types of cancer, but patient response and side effects need to be closely monitored during use to achieve optimal treatment results.